Clinical Trials
2 trialsNCT05035914 2021-09-05
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
Guangzhou University of Traditional Chinese Medicine
Phase 1/2 Unknown
NCT04929652 2021-06-18
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 1/2 Unknown